KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teradyne (TER) Gains from Sales and Divestitures (2016 - 2024)

Historic Gains from Sales and Divestitures for Teradyne (TER) over the last 13 years, with Q4 2024 value amounting to $492000.0.

  • Teradyne's Gains from Sales and Divestitures fell 1921.18% to $492000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $492000.0, marking a year-over-year decrease of 1921.18%. This contributed to the annual value of $492000.0 for FY2024, which is 1921.18% down from last year.
  • Teradyne's Gains from Sales and Divestitures amounted to $492000.0 in Q4 2024, which was down 1921.18% from $609000.0 recorded in Q4 2023.
  • Over the past 5 years, Teradyne's Gains from Sales and Divestitures peaked at $749000.0 during Q4 2021, and registered a low of $492000.0 during Q4 2024.
  • In the last 4 years, Teradyne's Gains from Sales and Divestitures had a median value of $659000.0 in 2022 and averaged $639750.0.
  • In the last 5 years, Teradyne's Gains from Sales and Divestitures crashed by 534.05% in 2022 and then tumbled by 1921.18% in 2024.
  • Over the past 4 years, Teradyne's Gains from Sales and Divestitures (Quarter) stood at $749000.0 in 2021, then dropped by 5.34% to $709000.0 in 2022, then decreased by 14.1% to $609000.0 in 2023, then decreased by 19.21% to $492000.0 in 2024.
  • Its Gains from Sales and Divestitures was $492000.0 in Q4 2024, compared to $609000.0 in Q4 2023 and $709000.0 in Q4 2022.